Luc Mongeau
appointed Luc Mongeau, a current member of the Board, to serve as Chief Executive Officer (“CEO”) of the Company (the “Appointment”), effective January 6, 2025
Highest-materiality recent filing
Canopy Growth Q4 revenue +10% to $71.2M; net loss narrows 21%; targets positive EBITDA in FY2027
Consolidated Q4 net revenue $71.2M (+10% YoY); full-year $284.6M (+6%).
Canopy Growth adopts advance notice bylaw for shareholder director nominations
Board approved Advance Notice By-Law No. 2 effective May 26, 2026, establishing formal nomination procedures for director elections.
Non-reliance on FY2024, FY2025 audited financials and 8 quarterly periods due to accounting error on USD-denominated share-settled warrants misclassified as equity.
Acquired all MTL shares for ~41.2M CGC shares + C$18.5M cash; 0.32 CGC share + C$0.144 cash per MTL share.
Canopy Q3 net loss narrows 49% YoY; Canada cannabis revenue up 4% to $52M
Net loss narrowed 49% YoY; Adjusted EBITDA loss narrowed 17% to $3M; free cash outflow improved to $19M.
Term loan net proceeds of US$150M (US$162M principal with OID), interest at Term SOFR +6.25% (floor 3.25%), matures Jan 2031.
Canopy Growth to acquire MTL Cannabis in stock-and-cash deal valued at ~38M shares + C$17M
Exchange ratio: 0.32 CGC share + C$0.144 cash per MTL share; aggregate approx. 38M CGC shares and C$17M cash.
Canopy Growth Q2 revenue $67M (+6% YoY); going concern doubt resolved
Canada adult-use net revenue $24M, up 30% YoY; Canada medical $22M, up 17%.
Canopy Growth shareholders approve reverse stock split at 1:5 to 1:15 ratio
Share consolidation (reverse split) authorized with ratio of 1 post-split for every 5-15 pre-split shares, Board to set exact ratio before Sep 26, 2026.
Canopy Growth appoints interim CFO Tom Stewart as permanent CFO
Appointment effective September 17, 2025; Stewart had served as interim CFO since July 2025.
Canopy Growth launches $200M at-the-market equity program to strengthen financial position
New ATM program authorizes up to $200M in common shares, with up to $50M sold in Canada.
Canopy Growth Q1 FY2026 cannabis revenue up 24% YoY; appoints Shan Atkins to board
Cannabis net revenue $57M (+24% YoY); Canada adult-use up 43% to $27M on infused PRJ demand.
Canopy Growth to prepay US$50M of term loan, expects US$6.5M annual interest savings
Agrees to three prepayments: US$25M on July 31, 2025; US$10M by Dec 31, 2025; US$15M by Mar 31, 2026.
Canopy Growth terminates CFO Judy Hong without cause, appoints Tom Stewart as interim CFO
Judy Hong terminated as CFO on July 9, 2025, without cause; no relation to financial results or reporting practices.
Canopy Growth Q4 revenue down 11% YoY to $65M; adjusted EBITDA loss improves 39% to $9.2M
Net revenue $65M in Q4 FY2025, down 11% YoY; net loss from continuing ops $221.5M.
Canopy Growth prepays US$100M of term loan, cuts annual interest by ~US$13M
Optional early prepayment of US$100M principal at US$97.5M discount under Term Loan Amendment.
Canopy Growth enters $200M ATM equity distribution agreement with BMO
New ATM facility allows sale of up to $200M common shares via BMO Capital Markets and BMO Nesbitt Burns.
Canopy Growth Reports Q3 FY2025 Results: Revenue Down 5%, Adjusted EBITDA Improves 61%
Net revenue was $74.8M, down 5% YoY but up 8% excluding divestitures.
Canopy Growth files prospectus supplement for resale of 7.63M shares by selling securityholders
Prospectus supplement filed for resale of 7,631,637 common shares by selling securityholders.
Canopy USA completes acquisition of Acreage; CGC issues ~5.89M shares for deal value ~$21.2M
Canopy USA owns 100% of Acreage as of Dec 9, 2024; combined with Wana and Jetty for U.S. cannabis platform.
Canopy Growth names board member Luc Mongeau as CEO, effective Jan 6, 2025
Luc Mongeau, CPG veteran and board member since Feb 2024, becomes CEO on Jan 6, 2025; David Klein steps down to special advisor.
Canopy Growth Q2 revenue down 9% to $63M; adjusted EBITDA loss improves 54% to $5.5M
Net revenue $63.0M, down 9% YoY; excluding divested businesses, up 3%.
Canopy Growth prepays US$100M of term loan at discount; saves ~US$14M annually
Prepaid US$100M principal at discounted price of US$97.5M, reducing leverage.
All five director nominees (Klein, Kruh, Lazzarato, Mongeau, Yanofsky) elected with over 87% of votes cast for each.
Canopy Growth grants $150K retention bonuses to CFO and Chief Legal Officer through Oct 2025
CFO Judy Hong and CLO Christelle Gedeon each eligible for $150K retention bonus.
Canopy Growth announces CEO David Klein to retire by March 31, 2025; board begins successor search
CEO David Klein will retire by March 31, 2025; remains CEO until successor appointed or that date.
Canopy Growth Q1 revenue $66.2M (-13% YoY); gross profit up 67%; extends term loan to Dec 2026
Gross profit $23M (+67% YoY); gross margin 35% (+1,700 bps) on cost savings and medical mix.
Canopy Growth enters $250M at-the-market equity distribution agreement
Up to $250M (or equivalent CAD) of common shares may be sold through BMO Capital Markets (US) and BMO Nesbitt Burns (Canada).
Canopy Growth exercises Acreage share option, acquires $99.8M debt, closes Wana/Jetty buys
Exercised Fixed Share Call Option to acquire all Acreage Class E shares; closing subject to conditions.
Canopy Growth files resale registration for 20.9M shares held by selling securityholders
Prospectus supplement filed June 5, 2024 registers 20,949,390 common shares for resale by certain selling securityholders.
Canopy Growth Q4 net revenue up 7% YoY to $72.8M; adjusted EBITDA loss improves 63%
Q4 net revenue $72.8M (+7% YoY); Storz & Bickel net revenue up 43% to $22.2M on Venty sales.
Canopy Growth extends Acreage acquisition deadline to June 17, 2024
Eighth amendment to Floating Share Arrangement Agreement extends Exercise Outside Date from May 9 to June 17, 2024.
Canopy Growth enters debt exchange for US$50M proceeds, extends C$27.5M debt to 2029
Gross proceeds ~US$50M; exchanges C$27.5M of 2025 debt for new C$96.4M convertible debenture maturing 2029.
Canopy Growth extends outside date for Acreage acquisition to May 9, 2024
Exercise Outside Date under Floating Share Arrangement pushed from April 30 to May 9, 2024.
Canopy Growth converts C$81.2M note to exchangeable shares; CBI directors resign, debt down C$100M
C$81.2M of promissory note converted into 9,111,549 exchangeable shares at C$8.91/share; remaining C$18.8M principal and interest forgiven.
Canopy Growth shareholders approve Exchangeable Shares creation, enabling U.S. THC market entry
95.56% voted for amendment to create Exchangeable Shares, convertible into common shares.
Canopy Growth extends deadline to acquire Acreage Holdings to April 30, 2024
Sixth amendment to floating share arrangement agreement pushes Exercise Outside Date from March 31 to April 30, 2024.
Canopy Growth Q3 FY2024 revenue $78.5M; adjusted EBITDA loss narrows 82% to $9M
Net revenue $78.5M, down 7% YoY; net loss from continuing operations $230.3M.
Canopy Growth raises $35M in upsized private placement; proceeds to pay down debt
Sold 8.16M units at $4.29/unit for gross proceeds ~$35M; net proceeds ~$32.5M after fees.
Canopy Growth terminates $30M private placement agreement with institutional investors
Agreed to sell 6,993,007 units at $4.29/unit for approx. $30M on Jan 9; terminated Jan 12 due to third-party delays.
Canopy Growth extends outside date for Acreage acquisition to March 31, 2024
Fifth amendment extends Exercise Outside Date from Dec 31, 2023 to March 31, 2024.
Canopy Growth implements 1-for-10 reverse split; sells This Works brand for up to £9.3M
Share consolidation at 10:1 ratio effective December 15, 2023; trading begins December 20, 2023.
Canopy Growth Q2 FY2024 net revenue $69.6M, net loss $148.2M; gross margin 34%
Net revenue $69.6M, down 21% YoY; net loss $148.2M improved 25% vs Q2 FY2023 loss.
Canopy Growth extends Acreage acquisition deadline to Dec 31, 2023
Fourth amendment to arrangement agreement pushes Exercise Outside Date from Oct 31 to Dec 31, 2023.
Sold Hershey Drive facility to Hershey Canada, Inc. for approx. CAD $53M cash.
Canopy Growth shareholders approve share consolidation and new equity incentive plan
Share consolidation resolution passed with 322.6M for, 25.3M against (no broker non-votes).
Canopy Growth raises up to $50M in private placement of units at $1.09/unit
Initial closing: 22,929,468 units at $1.09/unit for $25M gross proceeds.
Canopy Growth ceases BioSteel funding; BioSteel files for creditor protection
BioSteel entered CCAA creditor protection; Canopy Growth ceased funding, cutting ~60% of Q1 FY2024 Adj. EBITDA loss.
Canopy Growth extends Acreage acquisition deadline to Oct 31, 2023
Third amendment to Floating Share Arrangement extends Exercise Outside Date from Aug 31 to Oct 31, 2023.
Canopy Growth issues 15.2M shares to acquire remaining 45% stake in Les Serres Vert Cannabis
Issued 15,206,046 common shares to LSB on Aug 29, 2023, as consideration for the remaining 45% interest in Les Serres Vert Cannabis.
appointed Luc Mongeau, a current member of the Board, to serve as Chief Executive Officer (“CEO”) of the Company (the “Appointment”), effective January 6, 2025
Mr. Klein will continue in his role as CEO and a member of the Board until the Start Date, at which time Mr. Klein will step down from the Board and will serve as Special Advisor
On August 15, 2024, Canopy Growth Corporation (the “Company”) entered into a Mutual Separation Agreement (the “Separation Agreement”) with David Klein, the Company’s Chief Executive Officer (“CEO”), pursuant to which Mr. Klein will remain as CEO until the earlier of: (i) March 31, 2025; or (ii) the date that a new CEO commences employment (the “End Date”).
Garth Hankinson, Judy Schmeling and James Sabia each provided notice to the Company of his or her decision to resign from the Board effective immediately
Garth Hankinson, Judy Schmeling and James Sabia each provided notice to the Company of his or her decision to resign from the Board effective immediately
Garth Hankinson, Judy Schmeling and James Sabia each provided notice to the Company of his or her decision to resign from the Board effective immediately
Thomas Stewart, who had been serving as the Company’s Chief Accounting Officer and Principal Accounting Officer, transitioned to the position of Vice President, Finance of the Company and is no longer serving as the Company’s Principal Accounting Officer as of such date.
Effective as of Mr. Stewart’s transition on August 14, 2023, Judy Hong, the Company’s Chief Financial Officer (“CFO”) and Principal Financial Officer, was designated as the Company’s Principal Accounting Officer.
On November 30, 2022, Canopy Growth Corporation (the “Company”) terminated the Services Delivery Agreement, dated October 5, 2020, as amended (the “Services Agreement”), with Julious Grant, effective December 16, 2022 (the “Termination Date”).
On March 31, 2022, Canopy Growth Corporation (the “ Company ”) announced, among other things, that Judy Hong, who had been serving as the Company’s Chief Financial Officer on an interim basis since November 18, 2021, was appointed as the Company’s permanent Chief Financial Officer
On November 24, 2021, Mr. William Newlands notified Canopy Growth Corporation (the “ Company ”) of his resignation as a member of the board of directors of the Company (the “ Board ”), effective immediately.
On November 24, 2021, following receipt of Mr. William Newlands’ resignation, the Board appointed Mr. Garth Hankinson as a director of the Board, effective immediately.
Max materiality 0.85 · Median 0.68 · Most common event other_material